Correction to: Efficacy and safety of ixazomib plus lenalidomide and dexamethasone following injectable pibased therapy in relapsed/refractory multiple myeloma.
Ann Hematol
; 102(9): 2505, 2023 Sep.
Article
in En
| MEDLINE
| ID: mdl-37432416
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Ann Hematol
Journal subject:
HEMATOLOGIA
Year:
2023
Type:
Article
Affiliation country:
Japan